Detail akcie Smith & Nephew online

Business Summary: Smith & Nephew plc is a portfolio medical technology company. The Company is focused on the repair, regeneration, and replacement of soft and hard tissue. The Company's segments include Orthopaedics, which includes a range of hip, knee and shoulder implants used to replace diseased, damaged or worn joints, robotics-assisted enabling technologies that empower surgeons, and trauma products used to stabilize severe fractures and correct bone deformities; Sports Medicine & ENT businesses offer advanced products and instruments used to repair or remove soft tissue, and Advanced Wound Management provides a comprehensive set of products to meet broad and complex clinical needs, and to help healthcare professionals reduce the human and economic consequences of wounds. The Company also owns Integrity Orthopaedics, which is an early stage commercial developer of Tendon Seam, an innovative and disruptive biomechanical RCR system.
Financial Summary: BRIEF: For the fiscal year ended 31 December 2025, Smith & Nephew plc revenues increased 6% to $6.16B. Net income increased 52% to $625M. Revenues reflect Orthopaedics segment increase of 6% to $2.44B, Advanced Wound Management segment increase of 7% to $1.79B, Sports Medicine & ENT segment increase of 6% to $1.93B, Other Established Markets segment increase of 17% to $1.48B, United States of America segment increase of 6% to $3.31B.